Manhattan biotech startup to commercialize MD Anderson research
August 13, 2018 at 12:21 PM EDT
A biotech startup that's developing a drug to slow the effects of neurodegenerative disease and brain injury will announce plans today to plant its flag in Manhattan. The company, Magnolia... To view the full story, click the title link.